5-Fluorouracil (5-FU) is a drug that belong to the antimetabolite class of antineoplastic agents, with a broad spectrum of activity against solid tumors, the use of oral 5-FU was abandoned decades ago because of its irregular absorption and rapid degradation. A potential strategy to improve the selective properties of 5-FU is the chemical transformation into reversible derivatives (prodrugs) which are converted to the parent drug by virtue of enzymatic or chemical means. In the present study, three derivatives of 5-fluorouracil have been designed to be synthesized as an azo derivatives of 5-fluorouracil in order to selectively deliver 5-fluorouracil into the cancer cells of the colon. The synthesis of the target compounds were accompli...
To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine ...
The fluoropyrimidine anticancer agent 5-fluorouracil (5-FU) is active in a wide range of solid tumor...
5-Fluorouracil (5-FU) is an antineoplastic antimetabolite that is widely administered to cancer pati...
5-Fluorouracil (5-FU) has become one of the most widely employed antimetabolite chemotherapeutic age...
5-Fluorouracil (5-FU) has become one of the most widely employed antimetabolite chemotherapeutic age...
In the present study, five derivatives have been designed to be synthesized as possible mutual prodr...
5-Fluorouracil (5-FU) is an antineoplastic antimetabolite that is widely administered to cancer pati...
A reproducible, sensitive, accurate and selective high performance liquid chromatographic (HPLC) met...
5-Fluorouracil (5-FU) is administered based on standard body surface area (BSA) dosing. BSA administ...
5-Fluorouracil (5-FU) being a mainstream anticancer drug is under keen and detailed investigation fo...
5-Fluorouracil (5-FU) is administered based on standard body surface area (BSA) dosing. BSA administ...
Objective: 5-Fluorouracil (5-FU) and celecoxib (Cel) combination offered additive effect in the trea...
We are grateful to the EPSRC (EP/N021134/1) for funding. T.L.B. thanks the CMVM of the University of...
The studies of potentiation of 5-fluorouracil (5-FU), a traditional drug used in the treatment of se...
To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine ...
To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine ...
The fluoropyrimidine anticancer agent 5-fluorouracil (5-FU) is active in a wide range of solid tumor...
5-Fluorouracil (5-FU) is an antineoplastic antimetabolite that is widely administered to cancer pati...
5-Fluorouracil (5-FU) has become one of the most widely employed antimetabolite chemotherapeutic age...
5-Fluorouracil (5-FU) has become one of the most widely employed antimetabolite chemotherapeutic age...
In the present study, five derivatives have been designed to be synthesized as possible mutual prodr...
5-Fluorouracil (5-FU) is an antineoplastic antimetabolite that is widely administered to cancer pati...
A reproducible, sensitive, accurate and selective high performance liquid chromatographic (HPLC) met...
5-Fluorouracil (5-FU) is administered based on standard body surface area (BSA) dosing. BSA administ...
5-Fluorouracil (5-FU) being a mainstream anticancer drug is under keen and detailed investigation fo...
5-Fluorouracil (5-FU) is administered based on standard body surface area (BSA) dosing. BSA administ...
Objective: 5-Fluorouracil (5-FU) and celecoxib (Cel) combination offered additive effect in the trea...
We are grateful to the EPSRC (EP/N021134/1) for funding. T.L.B. thanks the CMVM of the University of...
The studies of potentiation of 5-fluorouracil (5-FU), a traditional drug used in the treatment of se...
To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine ...
To assess the impact of the 5-fluorouracil (5-FU) drug-pathway genes on cytotoxicity, and determine ...
The fluoropyrimidine anticancer agent 5-fluorouracil (5-FU) is active in a wide range of solid tumor...
5-Fluorouracil (5-FU) is an antineoplastic antimetabolite that is widely administered to cancer pati...